Terremoto: A Word, A Movement, A Multidimensional Force
An "earthquake" is the equivalent term in English, "terremoto"—the Italian and Spanish word that is more impactful, disruptive, and changing. In addition to its denotative meaning, the terremoto has been a language of innovation and change across art and design, bioscience, and architecture. Here, we have discussed a few of them to understand the breadth and depth of its impact upon these sectors.
General Information about Terremoto
Generally, an earthquake is a natural disaster phenomena caused by the sudden movement of the earth's crust.
Concerning the disturbance of nature, earthquakes have always been a compelling topic for researchers, governments, and citizens due to their destructive force and seismic impacts on the living and the environment.
Nowadays, in the world, terremoto is also associated with the ideas of creativity and society—a brand or a name used by prominent contributors in the fields of art, design, science, and business.
Terremoto Book
Terremoto is the name given to a number of books, both in the category of fiction and non-fiction, that have been published.
Using the term as a metaphor, some authors have written forcefully that real-life terrible incidents have resulted in them or their characters never being the same again.
Old, especially Latin American literature, recall historical earthquakes or social disturbances as ways that have been made to change the society. Through these books, the themes of disorder, transformation, and recovery are often explored.
Terremoto Architectural League
Terremoto is a landscape architecture firm in Los Angeles, California that has attracted the attention of the Architectural League of New York for their innovative and climate-friendly methodologies for land design.
Their work unites art and local ecology in a sustainable way while still using the earth, water, and air as the media, and presenting urban realms as the primary target of architectural innovation—terremoto being the real example of this.
Terremoto Landscape on Instagram
The Instagram page @terremoto_landscape is more of a spot where people are coming to express their point of view visually than it is a profile.
The company gives its followers a tour of the backstage of their made and under construction projects through photos, drawings, and notes, shows their atypical mindset with playful and thoughtful captions as well as the arrangements of some wild plants, and share other weird things that can still put you right on their track of thinking about the earth.
Official Website of Terremoto LA
The official website of Terremoto Landscape Architecture company is available at www.terremoto.la. On the site, you will get the opportunity to read about:
-
Projects in the form of catalogs from all around California and even including other states.
-
The innovations in the area of gardening, ecology, and resistance in the form of philosophical essays.
-
Bios of the team in order to see the company’s inclusive and interdisciplinary staff.
-
Concepts and ideas on land management
-
ship and their "anti-masterplan" approach to land stewardship
This is not only a very resourceful site for those who love design, but it is also a place where you’ll get great information for your protesting campaign and the wisdom of the earth.
Andy Jones
Terremoto Biosciences
Terremoto Biosciences is working in the field of biotechnology and is one of the leading companies that has taken the pharmaceutical industry to another level.
Lately, the company has not only been making but also making big waves by the manufacture of small-molecular degraders, 'molecular glues' such as VHL-based molecules that induce degradation of specific proteins and can treat diseases that were previously considered untreatable.
A Seismic Shift in Drug Discovery
A shift in the focus area of Terremoto Biosciences is to go to the stage of protein functionalities. These non-inhibitors “molecular glues” always aim at the root of the disease by the eradication of the proteins apart from the same source.
Founding Team and Vision
Some scientific entrepreneurs who had been in the field of biotechnology for a very long time started Terremoto because the company’s mission is to change drug discovery as we know it.
The team has the necessary pool of talent in structural biology, chemistry, and genomics to challenge undruggable targets in a straightforward manner.
Series A and Series B Financing
- Series A: In the early stage of Terremoto, $75 million was amassed through the primary funding, and the leader of the pack was biotech investors that mostly concentrate on early-stage innovation.
- Series B: After that, they were successful in gathering $175 million in Series B, which showed that investors’ confidence was strong and they also had the capacity to set up clinical trials.
This money will be used to increase the number of platforms, to hire more staff, and for the preclinical phase of development.
Leadership and Strategic Appointments
Leading executives who play a major part in the success of Terremoto are as follows:
- Dr. Jonathan Montagu, CEO, known for his previous biotech exits
- Dr. Chris Arendt, Chief Scientific Officer, who is a specialist in immunology
- Board members from Third Rock Ventures and OrbiMed
These leaders are a combination of science, business strategy, and startup agility.
Collaborations and Partnerships
The company has connected with the top pharmaceutical companies and research institutions forming alliances in the biotech space.
The interconnections give them fast-track pipelines in drug discovery while allowing the wider adoption of u(I can) technology.
Contact Information
Do get in touch with Terremoto Biosciences via their official website: 👉 https://www.terremotobio.com
www.terremotobio.com
To get in touch for media or partnership: 📧 info@terremotobio.com
Headquarters: 📍 South San Francisco, California
To sum up
In the light of growing interest in the degradation of targeted proteins, Terremoto is ready to be the one who changes the game in biopharma considerably.
The first product of their clinical portfolio is about to enter human trials no later than within the following 18-24 months, which will be a significant breakthrough.
Imitation is the highest form of flattery.
